NLRP3 and hearing loss disorder: Previous studies have shown that cisplatin can trigger the assembly of the NLRP3 inflammasome and activate downstream pathways (44, 45); thus, we speculated that the NLRP3 inflammasome may also have a vital effect on the pathogenesis of cisplatin-induced hearing loss.